2015
$220M
from 16 investors over 16 rounds
Arcus Biosciences raised $220M on February 1, 2021
Investors: Gilead Sciences
Arcus Biosciences raised $200M on May 28, 2020
Investors: Gilead Sciences
Arcus Biosciences raised $107M on November 13, 2017
Investors: Leerink Partners LLC, Research Division, The Column Group, GV, The Invus Group, Hillhouse Capital Management, Wellington Management and Foresite Capital
Arcus Biosciences raised $70M on September 1, 2016
Investors: GV, Foresite Capital, The Invus Group, The Column Group and Celgene
Arcus Biosciences raised $50M on May 1, 2015
Investors: Celgene and The Column Group